Methods of Recellularizing Tissue Transplant for Improved Transplantability
Summary
The USPTO published patent application US20260092253A1 for methods of recellularizing an organ or tissue matrix for improved transplantability. Inventors are Doris A. Taylor and Stefan M. Kren. The application was filed December 9, 2025, under application number 19413394. This publication provides public notice of the pending patent application but does not grant any patent rights.
What changed
The USPTO published a patent application for recellularizing tissue and organ matrices to improve transplant outcomes. The application covers methods for preparing donor organs and tissues by removing cellular material and repopulating the matrix with appropriate cells. Inventors Doris A. Taylor and Stefan M. Kren filed the application on December 9, 2025.
Patent applicants and stakeholders in regenerative medicine and transplant technology should monitor this application for examination progress and potential patent claims. There are no compliance deadlines or regulatory obligations associated with this publication. The application is informational and does not create any immediate legal requirements for any party.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS OF RECELLULARIZING A TISSUE OR ORGAN FOR IMPROVED TRANSPLANTABILITY
Application US20260092253A1 Kind: A1 Apr 02, 2026
Inventors
Doris A. Taylor, Stefan M. Kren
Abstract
Described herein are methods of recellularizing an organ or tissue matrix.
CPC Classifications
C12N 5/0062 A61L 27/3604 A61L 27/3808
Filing Date
2025-12-09
Application No.
19413394
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.